AR and cancer: More importantly, AR is increasingly recognized as a potent oncogenic factor that overexpressed in different types of human cancers, specifically, downregulation of AR expression or blocking its function, have shown promising pre-clinical results, suggesting that these strategies could enhance the effectiveness of conventional antitumoral approaches [16, 39–42].